Organized by BioPartner UK, M Ventures, Optimum Strategic Communications, Biotechnology Business Institute (BBI), and Ezenze Ltd, this edition of the Anglonordic Life Science Conference was one of the top networking and partnering events in the life sciences calendar, and a unique R&D-to-investor conference in the UK.

The conference welcomed 86 top-tier investor firms, setting the stage for a high-impact day of insight and opportunity. Attendees dove into future-focused panel discussions exploring the European investment landscape and emerging technologies.

Keynotes, pitches and partnering

The day opened with a powerful keynote from Dr. Göran Ando of Nouscom AG, whose address blended experience with foresight, offering a compelling glimpse into the future of healthcare and biotechnology. 

A standout highlight of the conference was 36 dynamic funding pitches from some of the most innovative biomedical and healthcare startups in Europe. Meanwhile, 1:1 partnering was buzzing all day long, with every meeting slot booked, a true testament to the demand for collaboration and discovery in the sector.

A personal touch

Sharing their experience of the conference, an attending delegate said, “This was one of the best events I have attended – not too large, so there was a personal touch and the quality of people was very high. I would definitely attend again, thank you.”

Exclusively selected attendees to the conference included CEOs, CSOs, and Business Development leaders from emerging Anglo-Nordic and European life science companies, alongside top decision-makers from leading investor firms, pharmaceutical giants, ecosystem enablers, and hand-picked country delegations from global life science clusters, together representing the key drivers of Europe’s life sciences growth.

Women’s health

Women’s Health took center stage at Anglonordic 2025 with a dedicated panel discussion that saw the highest attendance. This marks a long-overdue shift toward inclusive innovation and research. For too long, this area has been underrepresented in funding, clinical trials, and policy focus, but now there is a growing momentum that reflects a more equitable future for healthcare.

Delegates left London not only with valuable connections and insights but also with a renewed drive to shape the future of healthcare. 

With the 2026 edition already on the horizon, set for 23rd April – one thing is clear: the most exciting chapter of Anglonordic may still lie ahead.